Back
ESC Professional Premium Access

The eligibility of patients with an inherited cardiac disease for therapy with a subcutaneous implantable cardioverter-defibrillator.

Session: Device treatment of arrhythmias
Topic: Device Treatment
Speaker: Mr V. Proost (Amsterdam, NL)
Event: ESC Congress 2022

Congress Presentation

About the speaker

Mr Virginnio Proost

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))
0 follower

5 more presentations in this session

Subcutaneous Implantable Defibrillator programming: an analysis of Italian clinical practice and its evolution.

Speaker: Doctor S. Valsecchi (Milan, IT)

Access
Abstract
Slides
Thumbnail

3 Tesla magnetic resonance imaging in patients with cardiac electronic implantable devices: a single center experience

Speaker: Doctor J. Nikorowitsch (Hamburg, DE)

Access
Abstract
Slides
Thumbnail

Ventricular tachycardia ablation before an implantable cardioverter defibrillator in secondary prevention: is always the best option?

Speaker: Doctor A. Martinho (Coimbra, PT)

Access
Abstract
Slides
Thumbnail

Single-Chamber versus Dual-Chamber Pacing in very elderly patients with Sinus Node Disease and AV Block: A real-world study

Speaker: Doctor A. Bedir (Dartford, GB)

Access
Abstract
Slides
Thumbnail

Benefit of right inferior pacing on conduction across Bachmanns Bundle

Speaker: Mr M. Van Schie (Rotterdam, NL)

Access
Abstract
Slides
Thumbnail

Access the full session

Device treatment of arrhythmias

Speakers: Mr V. Proost, Doctor S. Valsecchi, Doctor J. Nikorowitsch, Doctor A. Martinho, Doctor A. Bedir...
Access
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb